Your Messages Inbox
Your Article Summary
See Latest ArticlesFull results from first Phase III study of Avastin in adjuvant colon cancer announced
Roche, 06/01/09
Full results from first Phase III study of Avastin in adjuvant colon cancer announced Results suggest future trials may hold promise for Avastin as early-stage colon cancer treatment even though C-08 study does not meet primary endpoint Full results from the first phase III trial of Avastin in early-stage colon cancer, known as NSABP C-08, were announced today. The study evaluated the use of Avastin plus chemotherapy for the treatment of colon cancer immediately following surgery compared to chemotherapy alone. The study showed the addition of one year of Avastin to chemotherapy did not result in a statistically significant improvement in overall disease-free survival .
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Article Search
Sponsor